PHVS
PHARVARIS (PHVS)
NASDAQ
$32.44-$0.18 (-0.57%)
Price as of Aug 03, 2026 11:22 AM EDT
  • $1.8B
    Market Cap
  • 63.10%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
GENERAL ATLANTIC, L.P.
11.49%
8.0M
0 (0.00%)
Mar 31, 2026
FMR LLC
8.99%
6.3M
-114,686 (-1.82%)
Mar 31, 2026
FORESITE CAPITAL MANAGEMENT IV, LLC
6.84%
4.8M
0 (0.00%)
Mar 31, 2026
VENBIO PARTNERS LLC
6.64%
4.6M
0 (0.00%)
Mar 31, 2026
VIKING GLOBAL INVESTORS LP
5.23%
3.7M
0 (0.00%)
Mar 31, 2026
EQT FUND MANAGEMENT S.A R.L.
4.90%
3.4M
0 (0.00%)
Mar 31, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
4.47%
3.1M
0 (0.00%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions586.8M (94.26%)
  • Mutual Funds34.9M (5.60%)
  • Insiders884,882 (0.14%)
  • Other0 (0.00%)

Insider Transactions

  • 0.14% (884,882)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 4
    Number of InsiderSelling (last 12 months)
  • $38.9M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Lu Peng
Chief Medical Officer
In Kind
Jul 12, 2026
$4,103.19
117
$35.07
65,405
Lu Peng
Chief Medical Officer
In Kind
Jul 11, 2026
$3,822.63
109
$35.07
65,522
Lesage Anne
Chief Early Development
Exempt
Jun 30, 2026
$0.00
2,972
$0.00
0
Lesage Anne
Chief Early Development
Exempt
Jun 30, 2026
$7,697.48
2,972
$2.59
61,722
Lesage Anne
Chief Early Development
Exempt
Jun 30, 2026
$200,445.00
24,900
$8.05
86,622
Lesage Anne
Chief Early Development
Sell
Jun 30, 2026
$988,890.20
27,872
$35.48
58,750
Lesage Anne
Chief Early Development
Exempt
Jun 30, 2026
$0.00
24,900
$0.00
45,000
Lesage Anne
Chief Early Development
Sell
Jun 30, 2026
$1.1M
30,703
$35.49
93,969
Schikan Johannes Gerardus Christiaan Petrus
Sell
Jun 29, 2026
$84,249.84
2,400
$35.10
352,767
Lesage Anne
Chief Early Development
Exempt
Jun 29, 2026
$0.00
4,200
$0.00
69,900
Lesage Anne
Chief Early Development
Exempt
Jun 29, 2026
$0.00
1,400
$0.00
7,072
Lesage Anne
Chief Early Development
Exempt
Jun 29, 2026
$0.00
4,100
$0.00
2,972
Lesage Anne
Chief Early Development
Sell
Jun 29, 2026
$245,231.56
6,997
$35.05
124,672
Lesage Anne
Chief Early Development
Exempt
Jun 29, 2026
$3,626.00
1,400
$2.59
57,850
Lesage Anne
Chief Early Development
Exempt
Jun 29, 2026
$7,245.00
900
$8.05
58,750
Lesage Anne
Chief Early Development
Exempt
Jun 29, 2026
$10,619.00
4,100
$2.59
56,450
Lesage Anne
Chief Early Development
Exempt
Jun 29, 2026
$33,810.00
4,200
$8.05
67,050
Lesage Anne
Chief Early Development
Sell
Jun 29, 2026
$80,785.66
2,300
$35.12
56,450
Lesage Anne
Chief Early Development
Sell
Jun 29, 2026
$290,907.53
8,300
$35.05
58,750
Lu Peng
Chief Medical Officer
Exempt
Jun 26, 2026
$0.00
14,700
$0.00
175,308
Lu Peng
Chief Medical Officer
Exempt
Jun 26, 2026
$38,073.00
14,700
$2.59
80,331
Lu Peng
Chief Medical Officer
Sell
Jun 26, 2026
$499,847.04
14,700
$34.00
65,631
Lu Peng
Chief Medical Officer
Exempt
Jun 25, 2026
$0.00
15,000
$0.00
190,008
Lu Peng
Chief Medical Officer
Exempt
Jun 25, 2026
$38,850.00
15,000
$2.59
80,631
Lu Peng
Chief Medical Officer
Sell
Jun 25, 2026
$399,674.52
11,600
$34.45
69,031
Lu Peng
Chief Medical Officer
Sell
Jun 25, 2026
$119,310.42
3,400
$35.09
65,631
Lu Peng
Chief Medical Officer
Exempt
Jun 18, 2026
$0.00
300
$0.00
205,008
Lu Peng
Chief Medical Officer
Exempt
Jun 18, 2026
$777.00
300
$2.59
65,931
Lu Peng
Chief Medical Officer
Sell
Jun 18, 2026
$10,200.00
300
$34.00
65,631
Lu Peng
Chief Medical Officer
In Kind
Jun 11, 2026
$3,434.59
109
$31.51
65,748